Skip to content

Clinical trials

Urinary Bladder Neoplasms trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Urinary Bladder Neoplasms Country / region: France Clear all

152 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20043
20052
20071
20084
20093
20101
20117
20133
20144
20155
20165
20177
201810
201913
202012
202122
20228
202312
20247
20259
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed70
Recruiting32
Terminated21
Active, not recruiting20
Unknown status6
Not yet recruiting2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC10
Bristol-Myers Squibb7
Eli Lilly and Company7
Hopital Foch6
Pfizer6
AstraZeneca5
European Organisation for Research and Treatment of Cancer - EORTC5
Janssen Research & Development, LLC5
Hoffmann-La Roche4
Institut Bergonié4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Urinary Bladder Neoplasms152
Carcinoma, Transitional Cell32
Ovarian Neoplasms20
Carcinoma, Non-Small-Cell Lung19
Neoplasms16
Non-Muscle Invasive Bladder Neoplasms15
Stomach Neoplasms15
Lung Neoplasms13
Melanoma13
Neoplasm Metastasis13

Trials

Showing 1 to 25 of 152. Each trial links to its page on Pharma Observatory.

52 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.